Open AccessP1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH‐TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID‐19 PANDEMIC
Author(s) -
Cai X.,
Zhang X.H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849468.68112.e2
Subject(s) - eltrombopag , medicine , romiplostim , immune thrombocytopenia , pandemic , immunology , thrombopoietin , covid-19 , platelet , disease , infectious disease (medical specialty) , genetics , stem cell , haematopoiesis , biology